The National Association of Pro-Life Nurses announced this week that it has joined the Alliance for Hippocratic Medicine in the landmark case against the Food and Drug Administration about the chemical abortion drug mifepristone.
The association’s president, Dorothy Kane, stated in a news release that the lawsuit, which is headed to the Supreme Court, “is about safeguarding women’s health, protecting the integrity of the healthcare profession, and committing to evidence-based care.”
Established in 1973, the National Association of Pro-Life Nurses is a nonprofit organization that promotes ethical values in the field of nursing and shares informational resources regarding bioethical issues.
“Nurses are on the front lines witnessing the serious harms to women caused by the FDA’s reckless removal of essential safeguards for the use of chemical abortion drugs,” Kane said. “Women deserve the ongoing, in-person care of a medical professional when taking high-risk drugs. The FDA has compromised patient safety and shown a callous disregard for women’s health and safety. This case is about safeguarding women’s health, protecting the integrity of the healthcare profession, and committing to evidence-based care.”
The Supreme Court is set to hear oral arguments for the case, U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine, on March 26. The plaintiffs argue that the FDA approved the chemical abortion drug mifepristone without sufficient research on its safety and effects. The plaintiffs also argue that the FDA illegally removed the requirement for in-person doctor visits before receiving a prescription for chemical abortion drugs.
The availability of mifepristone has increased within the last year, as CVS and Walgreens recently announced that they plan to prescribe the drug via mail.
REACH PRO-LIFE PEOPLE WORLDWIDE! Advertise with LifeNews to reach hundreds of thousands of pro-life readers every week. Contact us today.
The Supreme Court decision on the case will determine the availability and accessibility of mifepristone.
According to the National Association of Pro-Life Nurses, the FDA disregarded patient safety by removing safeguards despite the drug’s health risks and facilitated a lack of informed consent by removing requirements of in-person doctor visits for women seeking an abortion drug regime prescription.
The FDA’s own label for mifepristone and misoprostol states that one in 25 women who take the abortion drugs will end up in an emergency room, the association’s release said.
“The removal of abortion drug safety standards could lead to a greater number of complications, including hemorrhage, life-threatening infection, and incomplete abortions,” the release said.
LifeNews Note: McKenna Snow writes for CatholicVote, where this column originally appeared.
The post Nurses Group Tells Supreme Court to Protect Women From Dangerous Abortion Drugs appeared first on LifeNews.com.
Click this link for the original source of this article.
Author: McKenna Snow
This content is courtesy of, and owned and copyrighted by, https://www.lifenews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.